Abbott Recalls Glucose Monitors After Reports of Falsely Low Readings, 7 Deaths Linked

In Brief

Abbott recalled certain FreeStyle Libre 3 sensors after reports of falsely low glucose readings and links to 7 deaths.

Key Facts

• Abbott has recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems.
• The recall was issued due to warnings that the sensors could produce falsely low glucose readings.
• The Independent reports the recall follows links to 7 deaths.

What Happened

Abbott recalled specific sensors from its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitoring systems, warning that the devices could give falsely low glucose readings. The recall comes after reports linking these devices to 7 deaths.

Why It Matters

Accurate glucose monitoring is critical for diabetics, and falsely low readings may lead to inappropriate treatment decisions. The recall raises concerns about device reliability and patient safety. Based on a single source report

What's Next

Patients using the affected sensors are expected to follow Abbott's recall instructions. Regulatory agencies and Abbott may provide further updates as the situation develops.